Skip to Content

MYLAN 6089 MYLAN 6089 (Fenofibrate (Micronized) 130 mg)

Pill with imprint MYLAN 6089 MYLAN 6089 is Pink, Capsule-shape and has been identified as Fenofibrate (Micronized) 130 mg. It is supplied by Mylan Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 130 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 6089 MYLAN 6089

Fenofibrate (micronized) 130 mg MYLAN 6089 MYLAN 6089
Fenofibrate (micronized) 130 mg MYLAN 6089 MYLAN 6089
Fenofibrate (micronized) 130 mg MYLAN 6089 MYLAN 6089

Fenofibrate (Micronized)

Imprint
MYLAN 6089 MYLAN 6089
Strength
130 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-6089

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.